Three easily-implementable changes reduce median door-to-needle time for intravenous thrombolysis by 23 minutes

BMC Neurology

Table 2 Outcomes in the pre- and post-intervention groups at discharge

Outcomes	Patients receiving IVT		OR (95% CI)	p value	Adjusted OR (95% CI)^a	p value^a
Outcomes	Pre-intervention (n = 90)	Post-intervention (n = 136)	OR (95% CI)	p value	Adjusted OR (95% CI)^a	p value^a
sICH	1 (1.1)	2 (1.5)	1.33 (0.12–14.87)	0.817	1.15 (0.11–12.39)	0.911
mRS 0–1	21 (23.3)	40 (29.4)	1.37 (0.74–2.53)	0.314	1.01 (0.50–2.04)	0.983
mRS 5–6	39 (43.3)	34 (25.0)	0.44 (0.25–0.77)	0.004	0.53 (0.27–1.05)	0.068
mortality	6 (6.7)	10 (7.4)	1.11 (0.39–3.17)	0.844	1.33 (0.44–4.03)	0.619

Data are n (%)
sICH Symptomatic intracranial hemorrhage, OR Odds ratio, CI Confidence interval, IVT Intravenous thrombolysis, mRS Modified Rankin Scale
^aAdjusted for age, hypertension, diabetes, hyperlipidemia and baseline NIHSS

ISSN: 1471-2377